切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (03) : 251 -256. doi: 10.3877/cma.j.issn.1674-6902.2017.03.002

所属专题: 文献

论著

下调S100A6基因对裸鼠肺腺癌移植瘤生长和凋亡的影响
南岩东1,(), 姜华1, 房延凤1, 金发光1, 杨拴盈2   
  1. 1. 710038 西安,第四军医大学唐都医院呼吸与危重症医学科
    2. 710004 西安,西安交通大学第二附属医院呼吸内科
  • 收稿日期:2016-01-03 出版日期:2017-06-20
  • 通信作者: 南岩东
  • 基金资助:
    国家自然科学基金资助项目(81001040)

Influence of S100A6 gene down-regulation on growth and apoptosis of transplanted lung adenocarcinoma in nude rats

Yandong Nan1,(), Hua Jiang1, Yanfeng Fang1, Faguang Jin1, Shuanying Yang2   

  1. 1. Department of Respiratory Disease, Tangdu Hospital, Fourth Military Medical University, Xi′an 710038, China
    2. Department of Respiratory Disease, Second Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710004, China
  • Received:2016-01-03 Published:2017-06-20
  • Corresponding author: Yandong Nan
  • About author:
    Corresponding author: Nan Yandong, Email:
引用本文:

南岩东, 姜华, 房延凤, 金发光, 杨拴盈. 下调S100A6基因对裸鼠肺腺癌移植瘤生长和凋亡的影响[J]. 中华肺部疾病杂志(电子版), 2017, 10(03): 251-256.

Yandong Nan, Hua Jiang, Yanfeng Fang, Faguang Jin, Shuanying Yang. Influence of S100A6 gene down-regulation on growth and apoptosis of transplanted lung adenocarcinoma in nude rats[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(03): 251-256.

目的

探讨下调靶向基因S100A6对在体肺腺癌移植瘤生长和凋亡的影响。

方法

18只健康Balb/c雄性裸鼠随机分为空载体对照组、阴性对照组及S100A6基因RNA干扰组三组,每组6只动物;分别应用不携带目的基因的空载质粒、未转染任何质粒以及含有S100A6基因RNA干扰慢病毒质粒的A549肺腺癌细胞接种于裸鼠皮下,构建移植瘤动物模型;观察不同组移植瘤组织生长情况;采用Real-Time PCR、免疫组织化学及Western-blot等技术检测S100A6 mRNA和蛋白的表达,TUNEL法检测细胞凋亡。

结果

成功构建了裸鼠肺腺癌皮下移植瘤模型;病理学特征显示,阴性对照组和空载体对照组可见到成巢的肿瘤细胞,癌细胞核大,而干扰组肿瘤细胞较稀疏,间质组织明显;接种细胞2周时,阴性对照组、空载体对照组和RNA干扰组肿瘤组织体积和质量差异具有统计学意义(P<0.05);S100A6基因和蛋白表达在三组之间差异具有统计学意义(P<0.05);各组裸鼠移植瘤凋亡细胞呈现不同程度的棕褐色肿瘤细胞核,三组肿瘤细胞凋亡率的差异具有统计学意义(P<0.05)。

结论

下调肿瘤瘤组织S100A6蛋白表达,可抑制肿瘤生长,诱导细胞凋亡,为进一步开发肺腺癌分子靶点提供了新途径。

Objective

S100A6 can regulate cell proliferation, differentiation, cell cycle and apoptosis by interacting with target proteins under the condition of calcium ion existence. S100A6 gene is highly expressed in multiple tumor tissues and is closely related to the occurrence and development of tumor. The aim of this study is to explore the influence of S100A6 gene down-regulation on growth and apoptosis of transplanted lung adenocarcinoma in nude rats.

Methods

Eighteen healthy male Balb/c nude mice were randomly divided into three groups: empty vector control group (n=6), negative control group (n=6) and S100A6 gene RNA interference (RNAi) group (n=6). The transplanted lung adenocarcinoma models were established by subcutaneous injection of A549 lung adenocarcinoma cells line with empty vector, non-carrier vector and pLenR-GPH-shRNAi-S100A6, respectively. The growth of transplanted tumor in different groups was observed. The expression of S100A6 gene was detected using real-time PCR, immunohistochemistry and western-blot methods. Apoptosis cells were analyzed by Terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL).

Results

The transplanted lung adenocarcinoma models in nude rat were successfully established. The pathological features showed that typical tumor cells formed solid hest-like mass. The tumor cell nucleus in empty vector control group and negative control group got bigger. The tumor cells in S100A6 RNAi group were relatively looser and their interstitial components became obvious. The tumor volume and mass among three groups had significant difference(P<0.05). The expression of S100A6 gene of RNAi group was significantly lower than that of empty vector control group and negative control group(P<0.05). The apoptosis rate had significantly difference among three groups(P<0.05). The nucleus of apoptosis cell in transplanted lung adenocarcinoma showed brown.

Conclusions

Down-regulation expression of S100A6 in lung adenocarcinoma could inhibit tumor growth and induce cell apoptosis, which could provide new pathway for further study of molecular target spot of lung adenocarcinoma.

图1 慢病毒感染A549肺腺癌细胞72hGFP表达;注:A:阴性对照组;B:空载体对照组;C:S100A6RNA干扰组(×200)
图2 三组裸鼠接种A549肺腺癌细胞第14天成瘤情况观察;注:A:阴性对照组;B:空载体对照组;C:S100A6RNA干扰组
图3 三组裸鼠接种A549肺腺癌细胞14天成瘤肿瘤组织体积及质量比较;注:A:体积比较;B:质量比较;1:阴性对照组;2:空载体对照组;3:S100A6 RNA干扰组;*与阴性对照组相比,P<0.05;#与空载体对照组相比,P<0.05
图4 裸鼠成瘤HE染色组织标本;注:A:阴性对照组;B:空载体对照组;C:S100A6RNA干扰组(×200)
图5 Real-time PCR检测移植瘤组织S100A6mRNA表达;注:三组mRNA相对表达比较;*与阴性对照组相比,P<0.05;#与空载体对照组相比,P<0.05
图6 裸鼠成瘤S100A6免疫组织化学;注:A:阴性对照组;B:空载体对照组;C:S100A6RNA干扰组(×200)
表1 应用免疫组织化学法检测S100A6在三组移植瘤肿瘤组织差异表达
图7 Western-blot检测裸鼠成瘤S100A6蛋白表达;注:A: western-blot电泳条带,1-1阴性对照组,2-1空载体对照组,3-1 RNA干扰组;B:S100A6蛋白相对表达量比较,*与阴性对照组相比,P<0.05,#与空载体对照组相比,P<0.05
图8 TUNEL法检测移植瘤凋亡细胞及各组凋亡细胞数比较;注:A:阴性对照组,B:空载体对照组,C:RNA干扰组,D:各组凋亡细胞数比较,*与阴性对照组相比,P<0.05,#与空载体对照组相比,P<0.05(×400)
1
南岩东,房延凤,姜华,等. 基于免疫组化法分析肺腺癌S100A6蛋白表达与临床特征的关系[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(1): 15-19.
2
Ji YF, Huang H, Jiang F, et al. S100 family signaling network and related proteins in pancreatic cancer[J]. Int J Mol Med, 2014, 33 (4): 769-776.
3
Nan Y, Jin F, Yang S, et al. Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics[J]. Med Oncol, 2010, 27(4): 1398-1406.
4
Shen J, Xie Y, Sun ML, et al. Antitumor activity of cobrotoxin in human lung adenocarcinoma A549 cells and following transplantation in nude mice[J]. Oncol Lett, 2014, 8(5): 1961-1965.
5
Sato Y, Harada K, Sasaki M, et al. Clinicopathological significance of S100 protein expression in cholangiocarcinoma[J]. J Gastroenterol Hepatol, 2013, 28(8): 1422-1429.
6
Ishii A, Suzuki M, Satomi K, et al. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression[J]. Pathol Int, 2009, 59(9): 623-630.
7
Stradal TB, Gimona M. Ca(2+)-dependent association of S100A6 (Calcyclin) with the plasma membrane and the nuclear envelope[J]. J Biol Chem, 1999, 274(44):31593-31596.
8
Nowomy M, Bhattacharya S, Filipek A, et al. Characterization of the interaction of calcyclin(S100A6)and calcyclin binding protein[J]. J Bio1 Chem, 2000, 275(40): 31178-31182.
9
Ilg EC, Schafer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors[J]. Int J Cancer, 1996, 68 (3): 325-332.
10
南岩东,常蕊静,穆德广,等. 肿瘤相关蛋白质S100A6结构和功能的分析与预测[J]. 现代肿瘤医学,2013, 21(6): 1180-1184.
11
南岩东,马李杰,金发光,等. EF手型钙结合蛋白S100A6及其与肿瘤关系的研究进展[J]. 国际呼吸杂志,2014, 34 (20):1561-1565.
12
Yamaguchi H, Hanawa H, Uchida N, et al. Multi step pathogenesis of leukemia via the MLL-AF4 chimericgene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement o f S100A6 expression[J]. Exp Hematol, 2009, 37(6): 701-714.
13
Somnicki LP, Le′sniak W. S100A6 (calcyclin) deficiency induce ssenescence like changes in cell cycle, morphology and functional characteristics of mouse NIH3T3 fibroblasts[J]. J Cell Biochem, 2010, 109(3): 576-584.
14
Matsumoto T, Murao S, Kito K, et al. Modulation of S100 genes response to growth conditions in human epithelial tumor cells[J]. Pathol Int, 1997, 47(6): 339-346.
15
Tsoporis JN, Izhar S, Parker TG. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha[J]. J Biol Chem, 2008, 283(44): 30174-30183.
16
Leśniak W, Słomnicki ŁP, Filipek A. S100A6-new facts and features[J]. Biochem Biophys Res Commun, 2009, 390(4): 1087-1092.
17
Króliczak W, Pietrzak M, Puzianowska-Kuznicka M. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB[J]. Acta Biochim Pol, 2008, 55(3): 559-570.
18
Fernandez-Fernandez MR, Rutherford TJ, Fersht AR. Members of the S100 family bind p53 in two distinct ways[J]. Protein Sci, 2008, 17(10): 1663-1670.
19
Słomnicki ŁP, Nawrot B, Leśniak W. S100A6 binds p53 and affects its activity[J]. Int J Biochem Cell Biol, 2009, 41(4): 784-790.
[1] 赵鑫, 郝磊, 朱丽静, 土继政, 王博娟, 张凯, 王兴华. 超声造影评价肺腺癌与肺鳞癌血流灌注特征的价值研究[J]. 中华医学超声杂志(电子版), 2023, 20(11): 1181-1185.
[2] 张刚, 秦勇, 黄超, 薛震, 吕松岑. 基于骨关节炎软骨细胞表型转化的新兴治疗靶点[J]. 中华关节外科杂志(电子版), 2024, 18(03): 352-362.
[3] 王帆, 余辉, 谢佳乐, 许焕焕, 马瑞, 依日夏提·艾海提, 许珂, 许鹏. 成纤维样滑膜细胞在类风湿关节炎发病机制中的作用[J]. 中华关节外科杂志(电子版), 2024, 18(02): 225-230.
[4] 孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[5] 罗远杰, 杨靖梅, 孟姝, 敖逸博, 申道南. 槲皮素防治口腔疾病的研究进展[J]. 中华口腔医学研究杂志(电子版), 2024, 18(02): 117-122.
[6] 郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[7] 郑琪, 马婕群, 张彦兵, 廖子君, 张锐. EPHA5突变预测肺腺癌免疫检查点抑制剂治疗预后的临床意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 548-552.
[8] 刘静, 徐爽, 缪亚军. 肺腺癌miR-3653表达与高危型人乳头瘤病毒感染及预后的关系[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 600-604.
[9] 贾乃龙, 李传资, 王绥煌, 张余鹏, 林志华, 林昌昆, 黄垂志. 低剂量能谱CT结合多平面重建技术对肺癌和肺炎性结节鉴别诊断意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 247-251.
[10] 杨伟光, 喇焕之, 张元桢. 营养状态及血液常规指标对肺腺癌免疫不良反应的预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 829-832.
[11] 季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[12] 王颖, 吴德平, 刘煜, 刘国栋. miR-9-5p下调CXCR4减轻创伤性脑损伤大鼠的神经炎症和细胞凋亡[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(02): 65-72.
[13] 李景德, 张保艳, 卢培刚, 李博. 法舒地尔对大鼠急性脊髓损伤后神经细胞凋亡和BCL-2蛋白表达水平的影响[J]. 中华神经创伤外科电子杂志, 2024, 10(02): 65-70.
[14] 郑旭, 韩燕燕, 高珊, 李翀. 基于非标记定量蛋白质组学技术分析消岩汤干预人肺腺癌细胞后蛋白表达谱特征的影响[J]. 中华针灸电子杂志, 2024, 13(01): 18-23.
[15] 申磊磊, 刘有, 宁浩勇, 云天洋, 侯小明, 郭俊唐, 梁朝阳, 刘阳. 第8版肺癌TNM分期亚实性结节T分期建议方案的验证[J]. 中华胸部外科电子杂志, 2024, 11(01): 40-52.
阅读次数
全文


摘要